The SURPASS-4 trial is the first randomized controlled trial assessing cardiovascular outcomes with Tirzepatide [45]
If you developed gastroparesis, intestinal blockage, or vision loss after taking Ozempic or related GLP-1 medications, you may be eligible to seek compensation
More specifically, we used the following treatment options: (1) metformin monotherapy, (2) injectable monotherapy, (3) one non-metformin oral agent, (4) metformin and one other oral agent, (5) injectable and metformin, (6) injectable and one non-metformin agent, (7) two non-metformin oral agents, (8) metformin and two other oral agents, (9) injectable and metformin and one other agent, (10) injectable and two non-metformin agents, (11) three non-metformin oral agents or at least four agents
I leave it on the counter while I prepare for bed, and by the time Im ready, its at the perfect temperature